CAS RN: 614751-80-3

Gatifloxacin Hydrate

Product Availability

Choose a grade to view its available package options.

4 package records4 with current stock1 grade group
Batch No.PackageAvailabilityInquiry
Batchno.20260518 1g In stock Inquiry
Batchno.20250108 250mg In stock Inquiry
Batchno.20251006 25g In stock Inquiry
Batchno.20250303 5g In stock Inquiry
  • Product code: ICTG0325
  • Purity/Analytical Methods: >98.0%(HPLC)
GET A QUOTE

614751-80-3 / 1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid;hydrate

Standard CAS: 614751-80-3 Multi CAS: No

Basic Information

CAS
614751-80-3
Multi CAS
No
Molecular Formula
C19FH24N3O5
Molecular Weight
393.400000
Exact Mass
393.169999
InChI
InChI=1S/C19H22FN3O4.H2O/c1-10-8-22(6-5-21-10)16-14(20)7-12-15(18(16)27-2)23(11-3-4-11)9-13(17(12)24)19(25)26;/h7,9-11,21H,3-6,8H2,1-2H3,(H,25,26);1H2
InChIKey
IJOOSVJZBQQMBV-UHFFFAOYSA-N

Computed Properties

Structural Parameters

Heavy atom count
28
Aromatic heavy atom count
10
Fraction Csp3
0.47
Rotatable bonds
4
H-bond acceptors
6
H-bond donors
2
Molar refractivity
103.24
TPSA
115.3

LogP / Solubility

WLOGP
1.16
MLOGP
1.04
XLogP3
1.16
Consensus LogP
1.12
Log S (ESOL)
-3.01
Class (ESOL)
Poorly soluble
Log S (Ali)
-3.62
Class (Ali)
Poorly soluble
Log S (SILICOS-IT)
-3.66
Class (SILICOS-IT)
Poorly soluble

ADME

GI absorption
High
BBB permeant
No
P-gp substrate
No
CYP1A2 inhibitor
No
CYP2C19 inhibitor
No
CYP2C9 inhibitor
No
CYP2D6 inhibitor
Yes
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-4.3

Drug-likeness / Medicinal Chemistry

Lipinski
Yes
Ghose
Yes
Veber
Yes
Egan
Yes
Muegge
Yes
Bioavailability score
0.55
Leadlikeness
No
Synthetic Accessibility
3.5

Get In Touch

Contact Us